COMMUNIQUÉS West-GlobeNewswire

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
24/07/2026
Collaboration expands Zorronet's AI-powered detection, analysis and response capabilities into agricultural security, theft and critical transportation infrastructure protection NETANYA, Israel, July 24, 2026 (GLOBE [...]
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
24/07/2026
Company plans to request re-examination following negative CHMP opinion for arimoclomol MAA Zevra continues to support access to arimoclomol for eligible patients through its global Expanded Access Program BOSTON, July [...]
Dyadic Announces Continued Listing on the Nasdaq Capital Market
24/07/2026
JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions [...]
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
24/07/2026
NEW YORK and SYDNEY, July 24, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics Limited (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative [...]
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
24/07/2026
PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference
24/07/2026
Poster presentation builds on Phase 1b PP353 data published in The Lancet's eClinicalMedicine, reinforcing the rationale for a targeted, non-opioid approach to chronic Low Back Pain with Modic changes London, UK, 24 [...]
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
24/07/2026
Asimov will help build out protein production and characterization capabilities at Boston University's AI-programmable cloud laboratory, one of 20 nodes in the new NSF national network. Asimov will use these [...]
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
24/07/2026
PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results on Friday, August [...]
MannKind Announces $50 Million Private Placement
24/07/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient [...]
MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
24/07/2026
Transformative delivery option that may support earlier management of worsening fluid overload with a self-administered option designed for use outside the hospital setting Delivers IV-equivalent diuretic effect through [...]
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
24/07/2026
Susvimo is the first and only continuous delivery treatment that offers an alternative to standard of care eye injections for nAMD Positive recommendation is based on data from the LADDER, Archway and Portal studies [...]
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
24/07/2026
HUNTSVILLE, Ala., July 24, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug [...]
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
24/07/2026
Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews Paris, July 24, 2026. Sanofi today announced the discontinuation of clinical development of amlitelimab, an OX40- [...]
Communiqué de presse: Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales
24/07/2026
Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales Paris, le 24 juillet 2026. Sanofi a annoncé aujourd’hui l’arrêt du développement [...]
Ipsen provides update on Phase III BOLD trial in biliary atresia
24/07/2026
PARIS, FRANCE, 24 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III BOLD trial evaluating Bylvay versus placebo for patients living with biliary atresia (BA) who have already undergone a [...]
Ipsen fait le point sur l'essai de Phase III BOLD dans l'atrésie des voies biliaires
24/07/2026
PARIS, FRANCE, 24 JUILLET 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) a annoncé aujourd’hui que l'essai de Phase III BOLD, évaluant Bylvay versus placebo chez des patients atteints d'atrésie des voies biliaires (AVB) ayant [...]
Codexis Announces Pricing of Public Offering of Common Stock
24/07/2026
REDWOOD CITY, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, today [...]
SodaSlim Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
24/07/2026
SodaSlim's Caffeine Anhydrous, Green Tea Extract, Garcinia, Raspberry Ketone, and Green Coffee Bean Extract Amounts and Sourcing Ogden, UT, July 23, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by [...]
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
24/07/2026
ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed [...]

Pages